Your email has been successfully added to our mailing list.

×
0 0 -0.00689655172413794 -0.0620689655172413 -0.0482758620689654 -0.0555172413793102 -0.0483448275862068 -0.0503448275862069
Stock impact report

BRIEF-Precision Therapeutics Unit, Tumorgenesis, Announces License Agreement With Syntarray LLC [Reuters]

PRECISION THERAPEUTICS INC COMMON (AIPT) 
Company Research Source: Reuters
BRIEF-Precision Therapeutics Unit, Tumorgenesis, Announces License Agreement With Syntarray LLC | Reuters Reuters Staff 1 Min Read March 13 (Reuters) - Precision Therapeutics Inc: * PRECISION THERAPEUTICS SUBSIDIARY, TUMORGENESIS, ANNOUNCES LICENSE AGREEMENT WITH SYNTARRAY, LLC * PRECISION THERAPEUTICS - ? LICENSE AGREEMENT WILL ADVANCE PLAN TO DEVELOP PATIENT DERIVED TUMOR MODELS FOR PRECISION CANCER THERAPY, DRUG DEVELOPMENT? Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. © 2018 Reuters. All Rights Reserved. Show less Read more
Impact Snapshot
Event Time:
AIPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AIPT alerts
Opt-in for
AIPT alerts

from News Quantified
Opt-in for
AIPT alerts

from News Quantified